Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Last Updated: December 7, 2021

DrugPatentWatch Database Preview

Details for Patent: 10,344,765

Email this page to a colleague

« Back to Dashboard

Which drugs does patent 10,344,765 protect, and when does it expire?

Patent 10,344,765 protects PARSABIV and is included in one NDA.

This patent has forty-five patent family members in thirty-seven countries.

Summary for Patent: 10,344,765
Title:Stable liquid formulation of AMG 416 (etelcalcetide)
Abstract: A liquid formulation comprising a peptide agonist of the calcium sensing receptor and method of preparing and using the formulation are provided.
Inventor(s): Maclean; Derek (Los Altos, CA), Yin; Qun (Palo Alto, CA)
Assignee: Amgen Inc. (Thousand Oaks, CA)
Application Number:15/802,390
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 10,344,765
Patent Claim Types:
see list of patent claims
Formulation; Compound;

Drugs Protected by US Patent 10,344,765

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Kai Pharms Inc PARSABIV etelcalcetide SOLUTION;INTRAVENOUS 208325-001 Feb 7, 2017 RX Yes Yes ⤷  Try it Free ⤷  Try it Free Y ⤷  Try it Free
Kai Pharms Inc PARSABIV etelcalcetide SOLUTION;INTRAVENOUS 208325-002 Feb 7, 2017 RX Yes Yes ⤷  Try it Free ⤷  Try it Free Y ⤷  Try it Free
Kai Pharms Inc PARSABIV etelcalcetide SOLUTION;INTRAVENOUS 208325-003 Feb 7, 2017 RX Yes Yes ⤷  Try it Free ⤷  Try it Free Y ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,344,765

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 096773 ⤷  Try it Free
Australia 2014302122 ⤷  Try it Free
Brazil 112015032615 ⤷  Try it Free
Canada 2916222 ⤷  Try it Free
Chile 2015003738 ⤷  Try it Free
China 105764487 ⤷  Try it Free
Costa Rica 20160002 ⤷  Try it Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.